Side Effects of Untreated Growth Hormone Deficiency in Adults
Untreated growth hormone deficiency in an adult male with panhypopituitarism causes increased cardiovascular mortality, abnormal body composition with visceral obesity, reduced bone density with increased fracture risk, impaired quality of life, and increased risk of premature death. 1
Body Composition Abnormalities
The most consistent manifestation of untreated adult GHD is altered body composition:
- Increased total body fat mass with preferential accumulation of visceral (abdominal) fat 1
- Decreased lean body mass and reduced muscle mass compared to age- and sex-matched controls 1
- Reduced muscle strength affecting both isometric and isokinetic performance 1
- Decreased exercise capacity with reduced maximal oxygen consumption and maximum work capacity 1
- Reduced extracellular fluid volume 1, 2
These changes contribute to the characteristic appearance and functional limitations seen in untreated patients.
Skeletal Consequences
Bone health is significantly compromised in untreated GHD:
- Reduced bone mineral density (BMD) approximately 1 standard deviation below the mean 1
- 20% of adult-onset and 35% of childhood-onset patients have osteoporosis (T-scores ≤ -2.5) 1
- 2- to 5-fold increased fracture rates compared to non-GHD populations 1
- Age of GHD onset strongly affects severity—patients younger than 30 years have the most severe osteopenia 1
The severity of osteopenia correlates directly with the severity of GHD 1.
Cardiovascular and Metabolic Effects
Untreated GHD creates a high-risk cardiovascular profile:
- Increased cardiovascular mortality 2, 3
- Premature atherosclerosis with clinical signs 2
- Abnormal lipid profile predisposing to cardiovascular disease 4
- Reduced myocardial function 2
- Dyslipidemia 5
- Impaired cardiac performance 4
A recent population-based study demonstrated a 2.38-fold increased risk of cardiovascular disease (HR 2.38; 95% CI 1.84-3.07) 3.
Mortality Risk
Mortality is significantly increased in patients with hypopituitarism and untreated GHD 1:
- 1.61-fold increased risk of premature mortality (HR 1.61; 95% CI 1.27-2.03) 3
- The excess mortality is multifactorial, involving the underlying pituitary disease, inadequate hormone replacement, and the direct effects of GHD itself 6
Metabolic and Physiological Dysfunction
Multiple organ systems are affected:
- Reduced basal metabolic rate and energy expenditure 2
- Subnormal glomerular filtration rate and renal plasma flow 2
- Defective sweat secretion and thermoregulation 2
- Abnormal thyroid hormone metabolism 2
- Altered substrate metabolism 4
Quality of Life and Psychological Impact
The psychological burden is substantial and well-documented:
- Impaired psychological well-being compared to normal subjects 2, 4
- Reduced quality of life across multiple domains 4, 5
- Increased depression risk (HR 1.72; 95% CI 1.23-2.40) 3
- Reduced energy levels and vitality 7
- Long-term untreated patients show progressive decline in health status over time 7
Socioeconomic Consequences
Recent evidence reveals broader impacts:
- Increased unemployment risk (HR 2.06; 95% CI 1.56-2.71) 3
- Socioeconomic challenges compound the medical burden 3
Important Clinical Context for Panhypopituitarism
In your patient with panhypopituitarism (deficiencies in three or more pituitary axes), the diagnosis of GHD is highly likely and provocative testing may be optional if IGF-I is low 1. The presence of multiple pituitary hormone deficiencies strongly predicts GHD, with specificity comparable to provocative testing 1.
Critical Pitfall
The consequences of untreated GHD are progressive and cumulative—patients who remain untreated experience ongoing deterioration in physical mobility, energy levels, and overall health status over years 7. Early recognition and treatment are essential to prevent these irreversible complications, particularly the increased fracture risk and cardiovascular disease 3.